NANIU Research Chicago (01040) — Oak Brook, Illinois

NANIU Research Chicago (01040) is a clinical research site located in Oak Brook, Illinois, United States 60523.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

NANIU Research Chicago (01040) has participated in 1 clinical trials.

Therapeutic areas: C3G, IC-MPGN, C3 Glomerulopathy.

Sponsors: Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NANIU Research Chicago (01040)?

NANIU Research Chicago (01040) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NANIU Research Chicago (01040) conducted?

NANIU Research Chicago (01040) has 1 clinical trials on record. Their work covers C3G, IC-MPGN, C3 Glomerulopathy.

Is NANIU Research Chicago (01040) accredited by Crixeo Health?

NANIU Research Chicago (01040) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NANIU Research Chicago (01040)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.